BioCardia Inc (BCDA) 시세

Smelling news here.

Going right direction. WooHoo Turtle speed--but right direction now.

MMs finding some sellers for a while. Maybe I try for more shares.

Looks rather soft today as volume is down. So horde of seller is NOT happening is good. I think MMs get bored in 2 days and it creeps back up--my thoughts. I'm not selling unless a pop happens.

BCDA under $5

I think the 7.2mil may come from adding what the warrant holders can do? I don't know. But yes, I think they are going about enlarging the share structure intelligently. We'll see on the 3rd I guess. Weeee!

I made mistake of thinking new shares amounted to 7.2 million. New share amount is 4.8 M As shares priced at $3, this will not dip too far. Some are already added.so not expecting disaster like some stock adding shares.

Looks like their new share offering will be around $3 per share - https://www.globenewswire.com/news-release/2024/08/30/2938478/0/en/BioCardia-Announces-Pricing-of-Upsized-7-2-Million-Public-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html

Another 2.4 million issued under the same terms - https://ih.advfn.com/stock-market/NASDAQ/biocardia-BCDA/stock-news/94464814/form-s-1mef-registration-adding-securities-to-pr Hope this puppy can still keep treading water. Tomorrow's Friday, depending on who's buying this they may not want to hold over the weekend.

Well, those new shares being issued at half price are going to make it dip. Lot more to do with it than people's fear about it. But I've seen a lot of these Otc's, Pinky's and microcap Biopharma's issue a crapload of new shares right after news and a huge pop and then the share price collapses and people are stuck for months. Sometimes they never recover. The fact that BCDA absorbed them and moved into the 4's at end of day is pretty significant imo. The interest in buying it up in the low 3's means significant money likes the future outlook. Weeeeeeee! Microcap Biopharma!

I think that maybe people read both releases by now. Climbing up nicely. This never should have dipped so low. Some traders got a good deal today.

Interesting, thx. It looks like it might have legs...

At the moment, the trend is more towards $4 than $2
And such orders can be found Level 2 almost everywhere, but mostly these are so-called iceberg orders, where you only see a few thousand but there are hundreds of thousands behind them.
But in this day and age of electronic algorithms, this type of trading is relatively pointless and is no longer done.
Today's trading systems replenish certain positions again and again, buy and sell according to corresponding specifications and forward these promptly to the stock exchanges. This is why you can hardly find any relevant orders in the order books these days.

I have an L2. Volume is brisk right now. No walls set up on the ASK. 1700 shares is the highest. Most are 100 shares which most likely means the MMs aren't showing all of the shares they are selling at that PPS.

Do you have Level 2 on this? Curious what the ask prices are for the top 3-4 market makers. Also wondering if someone is holding out for a giant buy order in the $2something range.

On doing some more research around the inter-webs; Morningstar has given them a 5 star ranking and other ranking sites make it a moderate buy. So, apparently they're not full of crap. If it hangs around $3 for the close I'll be hopeful for it's future. ("it's called an investment", lolzzz thx.)

Also, it's not like the offering was needed to keep the lights on. The money gained from the offering will most likely go toward increased production of the approved product. It's called an investment. The company should realize good profits from the investment.

I have traded so many shares in the last few weeks and months that have issued new shares or announced new shares and closed in these huge volumes within the day.

You can see from the trading that the share wants to rise and will rise in line with the positive approval and the expected increase in profits and income.

It is simply our basic evil with these short addresses that are now headlessly beating up on every share that is even slightly up, regardless of whether there is good or bad news.

But this headless beating on shares very often brings the next 100-200% plus in trading the next day, because they then close the open positions as quickly as possible at all costs and then try the game all over again later out of sheer anger.
It is therefore no wonder why so many of them go bust. Well, it's not their money, but only that of their investors in these funds.

On a more general low float runner note; people always complain about "dilution" in penny stocks. But the reality is, if it's not a complete scam company who are just selling their shares into the pump, they have to issue more shares for there to be an increase in share price with the increase in attention and volume. These things don't really move up much or best case run way up with only a 1.5 million float. If I had got in and was down 30-50% I would just hang around and wait. I'm going to keep an eye on it anyway. An analyst, H.C. Wainright, whoever the hell that is, has put a price target of $25 per share on this thing. So, who knows. cheers!

With a current volume of 26.6 million, they won't wait a few days to see what happens and then issue new shares days later.
With today's volume, these announced new shares are already included three times or more in the volume and they can therefore be completed in one day and then celebrate the approval accordingly in the price the following days and generate a high increase.
There are only shorts at work here who think they can beat down the price with all their might and completely ignore the approval and the very good news that comes with it.
They have to cover their open positions very quickly otherwise the shot could backfire badly.

The total shares outstanding are 1.58 million, the float is 1.5 million. https://finviz.com/quote.ashx?t=BCDA&p=d Those issued shares and 2 types of warrants effectively triple the float. The shares can be bought at $2.47, the pre-funded warrants can be exercised immediately at .001. They can issue them at any time and in any amounts they want; so maybe parcel them out over the coming days, but I don't see how it cannot effect the share price in the near term. Just my non-professional, non-expert opinion. If their suite of catheter tools is something really new and different this will probably make everyone money. It's just going to be a buy and hold instead of a flip. I was going to get in this but saw that S-1 and changed my mind. I don't like to buy and hold. But, no one can predict the future. We'll see in the next couple of days. glta

Glad you see it the way I do. That 2m shares in a drop in the bucket.

With a trading volume of 22 million, what are 2.6 million new shares, they have long since been traded and the share price even rose further in the pre-market after this announcement.

A few shorts are only trading on this news with the new shares and are completely ignoring the top news.
I am sure that the share will turn around well today.

I don't see why the offering of 2,439,024 would tank the PPS the way it did. The offering shouldn't negate the news in the other PR. Maybe it will bounce back today.

BCDA: And indeed it DID, Dude; wherefore, a classic TOILET FLUSH on the Public --- as this Firm ramps-up to DUMP yet more shares onto the Wall Street 'playing field'.

If you're looking at the same screen I am there's a column of "Latest News" just to the right of the message board. The second press release down is a form S-1A released at 6:02am. I believe it has a strong bearing on which direction the price will take.

The News is top, it will bounce back around 5 bucks +

Wonder if it will bounce back over $4. It dropped fast at the bell.

Nice subs! Let's make some money.

NEWS_ BioCardia receives FDA clearance for new product
https://www.investing.com/news/company-news/biocardia-receives-fda-clearance-for-new-product-93CH-3592035

$BCDA +110% @ 4.62 in premarket on volume...

That's what I was thinking as well. Huge market for the drugs approved for sale.

BCDA 8k - If they issue a press release for this tomorrow morning should get real volume and keep moving up. https://ih.advfn.com/stock-market/NASDAQ/biocardia-BCDA/stock-news/94456844/form-8-k-current-report

They also submitted this for approval in July - https://www.biospace.com/biocardia-submits-for-fda-approval-of-morph-dna-steerable-introducer-product-family maybe it got approved?
Edit - here it is, looks like it's approved - https://ih.advfn.com/stock-market/NASDAQ/biocardia-BCDA/stock-news/94456844/form-8-k-current-report

BCDA; Did what?????? (NOTHING)

Whoops, I did it, again

BCDA new 52 low

BCDA new 52=week low

FDA Approves CardiAMP® Heart Failure II Protocol Amendment to Use Proprietary Cell Population Analysis Screening to Define Treatment

BCDA under $3

BCDA under $3

Understand and agree. They get little to no traction on the market. Although, most important imo is they do get traction with the largest health insurer in the country putting millions into BCDA's trials. Bizarre to me that few are paying attention to such a large indication as I'm sure you are aware with them being in such a late stage of their trials. Small burn and only need a small amount of capital to get to the Phase 3 readout. They already have 90% of the Phase 3 BCDA01 data, so I guess we will see what happens with the final data set.

Yes. Have a personal interest as I have heart disease.

Have traded it sporadically.

Disappointed that don’t ever seem to get much traction with this therapy even with good data.

Murocman

Been tracking this company for years. Anyone else?

BCDA new 52 week low

$BCDA catalysts;
''Our planned Morph-DNA submission to the FDA for approval of a product family from 5 French to 8 French diameters is on track for submission in the second quarter of 2024''
''Q2: Enrollment in the CardiAMP Cell Therapy Heart Failure Trial''
''Q2: Completion of low dose cohort''
''Q2: Third revenue sharing partnership agreement''

BCDA new 52 week low

BCDA new 52 week low

Watching news .. 08:17 AM EDT, 06/07/2024 (MT Newswires) -- BioCardia (BCDA) said Friday that the US Patent Office has granted a patent for the company's radial and transendocardial biotherapeutic delivery catheter through 2036.

The Helix biotherapeutic delivery system is being evaluated in ongoing clinical trials, according to BioCardia. It relates to medical procedures and systems for substance delivery to the heart through a radial artery and for the intracardiac delivery of cellular aggregates and other materials, the company said.

BioCardia's stock climbed more than 44% in recent Friday premarket activity.

Price: 6.3000, Change: +1.93, Percent Change: +44.16

Keep watching.........